Kura Oncology, Inc. - 10-Q Filing
Kura Oncology reports Q3 2025 financial results and discloses subsequent financing via Oberland Loan Agreement.
Tickers: $KURA
Kura Oncology reports Q3 2025 financial results and discloses subsequent financing via Oberland Loan Agreement.
Tickers: $KURA